4th Quarter - Amendment

KOUNTOUPES DENHAM CARR & REID, LLC for CVS HEALTH

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 16, 2020 $60,000 Replaced
4th Quarter - Amendment (this page) Mar 29, 2021 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about the pharmacy benefit manager/pharmacy and insurance industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, S. 1895 Lower Health Care Costs Act, S. 2543, The Prescription Drug Pricing Reduction Act, and H. R. 3, The Lower Drug Costs Now Act. H. R. 3502, the Protecting People from Surprise Medical Bills Act.

LobbyistCovered position, as disclosed
LORI DENHAM —
MJ KENNY —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2543 (116th), S. 476 (116th), H.R. 3502 (116th), S. 1895 (116th), H.R. 3 (116th)

Pharmacy PHA

General education about the pharmacy benefit manager/pharmacy industry, including spread pricing proposals and S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.

LobbyistCovered position, as disclosed
LORI DENHAM —
MJ KENNY New —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 340 (116th), S. 1227 (116th), S. 1895 (116th), S. 476 (116th), H.R. 965 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.